Trial intelligence / Profile preview

FMT in severe alcoholic hepatitis

NCT04758806Phase 3Unknown

Sponsor
University Hospital F.D. Roosevelt
Start
Apr 2018
Primary completion
Dec 2021
Modality
Live Biotherapeutic Products
Countries
1
01

Overview

A Phase 3 trial of allogeneic fecal microbiota in alcoholic hepatitis (AH), sponsored by University Hospital F.D. Roosevelt. Status: unknown.

02

Drugs

allogeneic fecal microbiota
03

Conditions

alcoholic hepatitis (AH)

Beyond the preview

Go deeper on NCT04758806.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04758806.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call